The Chasm We Must Cross in Japan for Re-promotion of the HPV Vaccine
Open Access
- 22 June 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 14 (7), 683-686
- https://doi.org/10.1158/1940-6207.capr-21-0091
Abstract
In Japan, the human papillomavirus (HPV) vaccination rate has decreased from around 70% to less than 1% due to repeated media reports of diverse symptoms after HPV vaccination, and to suspension of the governmental recommendation. The challenges for re-promotion of the vaccine will be discussed from a marketing perspective. The adopter categories by which a new product penetrates the market can be divided into five groups, including Innovators, Early adopters, Early majority, Late majority, and Laggards. The 16.0% line, which is the sum of the percentages of the innovators and the early adopters, is thought to be an important determinate of whether a new product will penetrate the market. By various initiatives, vaccination coverage has recently risen to about 10%; however, there is still a large chasm difficult to cross before reaching the majority of individuals. To cross that chasm, peer education will be essential. First, community health workers will need to be educated so that they have a firm understanding of HPV vaccine and can confidently recommend vaccination to the targeted population. That population will be expected to pass on that recommendation to their acquaintances, resulting in widening dissemination of HPV vaccine among the majority.Keywords
Funding Information
- Japan Agency for Medical Research and Development (15ck0106103h0102)
This publication has 20 references indexed in Scilit:
- No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya studyPapillomavirus Research, 2018
- Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth yearScientific Reports, 2018
- A behavioral economics approach to the failed HPV vaccination program in JapanVaccine, 2017
- Consensus statement from 17 relevant Japanese academic societies on the promotion of the human papillomavirus vaccineVaccine, 2017
- Development of an efficient strategy to improve HPV immunization coverage in JapanBMC Public Health, 2016
- Project conducted in Hirakata to improve cervical cancer screening rates in 20‐year‐old Japanese: Influencing parents to recommend that their daughters undergo cervical cancer screeningJournal of Obstetrics and Gynaecology Research, 2016
- Japanese Crisis of HPV VaccinationInternational Journal of Pathology and Clinical Research, 2016
- HPV vaccination crisis in JapanThe Lancet, 2015
- Japan’s failure to vaccinate girls against human papillomavirusAmerican Journal of Obstetrics and Gynecology, 2015
- Cost-effectiveness of a tailored intervention designed to increase breast cancer screening among a non-adherent population: a randomized controlled trialBMC Public Health, 2012